Your browser doesn't support javascript.
loading
Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.
Baumgaertner, P; Costa Nunes, C; Cachot, A; Maby-El Hajjami, H; Cagnon, L; Braun, M; Derré, L; Rivals, J-P; Rimoldi, D; Gnjatic, S; Abed Maillard, S; Marcos Mondéjar, P; Protti, M P; Romano, E; Michielin, O; Romero, P; Speiser, D E; Jandus, C.
Afiliación
  • Baumgaertner P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
  • Costa Nunes C; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
  • Cachot A; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
  • Maby-El Hajjami H; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.
  • Cagnon L; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.
  • Braun M; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
  • Derré L; Urology Research Unit, Urology Department, University Hospital Center (CHUV) , Lausanne, Switzerland.
  • Rivals JP; Department of Otorhinolaryngology - Head and Neck Surgery, CHUV, University of Lausanne , Switzerland.
  • Rimoldi D; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
  • Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, USA.
  • Abed Maillard S; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.
  • Marcos Mondéjar P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.
  • Protti MP; Tumor Immunology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Romano E; Department of Oncology, University Hospital Center (CHUV) , Lausanne, Switzerland.
  • Michielin O; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.
  • Romero P; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.
  • Speiser DE; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne, Switzerland; Department of Oncology, University Hospital Center (CHUV), Lausanne, Switzerland.
  • Jandus C; Ludwig Cancer Research Center, Department of Oncology, University of Lausanne , Switzerland.
Oncoimmunology ; 5(10): e1216290, 2016.
Article en En | MEDLINE | ID: mdl-27853637
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos